|
Aplastic anemia: history and recent developments in diagnosis and treatment |
Feb 2024 |
International Journal of Hematology |
Aplastic Anemia |
|
Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia |
Mar 2023 |
International Journal of Hematology |
Aplastic Anemia |
|
Progress in medical therapy in aplastic anemia: why it took so long? |
Feb 2024 |
International Journal of Hematology |
Aplastic Anemia |
|
High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity |
Jun 2020 |
International Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity |
Aug 2020 |
International Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges |
Aug 2020 |
International Journal of Laboratory Hematology |
Myelodysplastic Syndromes (MDS) |
|
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy |
May 2024 |
International Journal of Laboratory Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria |
May 2023 |
International Journal of Molecular Sciences |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study |
Dec 2019 |
JAMA Oncology |
Myelodysplastic Syndromes (MDS) |
|
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence |
Sep 2019 |
JCO Precision Oncology |
Myelodysplastic Syndromes (MDS) |
